Status:

COMPLETED

Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole

Lead Sponsor:

ThromboGenics

Conditions:

Vitreomacular Adhesion Including Macular Hole

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the treatment of symptomatic vitreomacular adhesion / (VMT) including macular hole with ocriplasmin.

Detailed Description

The present study is designed to assess anatomical and functional outcomes following a single intravitreal injection of ocriplasmin 0.125mg in subjects with symptomatic vitreomacular adhesion (VMA)/ (...

Eligibility Criteria

Inclusion

  • Subjects 18 years of age or older and of either gender
  • Presence of vitreomacular adhesion
  • Best corrected visual acuity (BCVA) of 20/32 or worse in study eye
  • BCVA of 20/800 or better in the non-study eye

Exclusion

  • History or current evidence of proliferative retinopathy, exudative age-related macular degeneration (AMD) or retinal vein occlusion in the study eye
  • Any vitreous hemorrhage or any other vitreous opacification which precludes the visualization of the posterior pole by visual inspection OR adequate assessment of the macula by spectral-domain optical coherence tomography (SD-OCT) in the study eye
  • Macular hole of \> 400 µm diameter in the study eye
  • Presence of epiretinal membrane (ERM)
  • Aphakia in the study eye
  • High myopia (more than 8D) in study eye
  • History of rhegmatogenous retinal detachment in either eye
  • History of vitrectomy in the study eye
  • Previous participation in this trial or prior administration of ocriplasmin in the study eye

Key Trial Info

Start Date :

October 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2014

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT01429441

Start Date

October 1 2011

End Date

October 1 2014

Last Update

March 14 2016

Active Locations (25)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (25 locations)

1

Retinal Consultants of Arizona

Phoenix, Arizona, United States, 85014

2

Retina-Vitreous Associates Medical Group

Beverly Hills, California, United States, 90211

3

Retina Consultants Medical Group

Sacramento, California, United States, 95819

4

West Coast Retina Group, Inc

San Francisco, California, United States, 94107